Two cell cycle blocks caused by iron chelation of neuroblastoma cells: separating cell cycle events associated with each block.

Autor: Siriwardana G; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado School of Medicine, 12700 E. 19th Avenue, Room 9122RC 2, MS B170, Aurora, 80045, Colorado., Seligman PA; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado School of Medicine, 12700 E. 19th Avenue, Room 9122RC 2, MS B170, Aurora, 80045, Colorado.
Jazyk: angličtina
Zdroj: Physiological reports [Physiol Rep] 2013 Dec 06; Vol. 1 (7), pp. e00176. Date of Electronic Publication: 2013 Dec 06 (Print Publication: 2013).
DOI: 10.1002/phy2.176
Abstrakt: Studies have presented evidence that besides the well described S phase block, treatment of cancer cell lines with the iron chelator deferrioxamine (DFO) also results in an earlier block in G1 phase. In this article, measurements of cell cycle regulatory proteins define this block at a very specific point in G1. DFO treatment results in markedly decreased cyclin A protein levels. Cyclin E levels that accumulate in early to mid-G1 are increased in cells treated with DFO as compared to the resting cells. The DFO S phase block is shown after cells are arrested at G1/S by (aphidicolin) then released into DFO. The same S phase block occurs with DFO treatment of a neuroblastoma cell line relatively resistant to the G1 DFO block. These experiments clearly differentiate the S phase DFO block from the earlier block pinpointed to a point in mid-G1, before G1/S when cyclin E protein increases but before increased cyclin A synthesis. Apoptosis was observed in cells inhibited by DFO at both cell cycle arrest points.
Databáze: MEDLINE